William E. Rote, Chief Research Officer: Travere Therapeutics TVTX Planned sale · Filed 09/15

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: William E. RoteChief Research Officer
Planned sale date: 26/09/15
Filed: 26/09/15

0.1% of shares outstanding to be sold

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 08/16~10/15

William E. Rote's recent trades

William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$7.1M
112,850 sh
$7.1M
Filed 09/16
Traded 09/16
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$355.7K
9,100 sh
$355.7K
Filed 04/23
Traded 04/22
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$355.7K
9,100 sh
$355.7K
Filed 04/22
Traded 04/22

William E. Rote, Chief Officer — plans to sell 96,198 sh of Travere Therapeutics TVTX · $6.3M · around 09/15 · 10b5-1 plan | Whalegun